HRP20160676T1 - Derivati biciklo[3.1.0]heksan-2,6-dikarboksilne kiseline kao agonisti receptora mglu2 - Google Patents

Derivati biciklo[3.1.0]heksan-2,6-dikarboksilne kiseline kao agonisti receptora mglu2

Info

Publication number
HRP20160676T1
HRP20160676T1 HRP20160676TT HRP20160676T HRP20160676T1 HR P20160676 T1 HRP20160676 T1 HR P20160676T1 HR P20160676T T HRP20160676T T HR P20160676TT HR P20160676 T HRP20160676 T HR P20160676T HR P20160676 T1 HRP20160676 T1 HR P20160676T1
Authority
HR
Croatia
Prior art keywords
hexan
bicycles
derivative
dicarboxylic acids
receptor agonists
Prior art date
Application number
HRP20160676TT
Other languages
English (en)
Croatian (hr)
Inventor
Teresa Tse Ki Man
James Allen Monn
Carlos Montero Salgado
Lourdes Prieto
Lesley Walton
David Edward Tupper
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of HRP20160676T1 publication Critical patent/HRP20160676T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20160676TT 2011-06-17 2012-06-07 Derivati biciklo[3.1.0]heksan-2,6-dikarboksilne kiseline kao agonisti receptora mglu2 HRP20160676T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP11382208 2011-06-17
US201161522791P 2011-08-12 2011-08-12
EP12729769.5A EP2721012B1 (en) 2011-06-17 2012-06-07 Bicyclo(3.1.0)hexane-2,6-dicarboxylic acid derivatives as mglu2 receptor agonist
PCT/US2012/041229 WO2012173850A1 (en) 2011-06-17 2012-06-07 Bicyclo (3.1.0) hexane- 2, 6 -dicarboxylic acid derivatives as mglu2 receptor agonist

Publications (1)

Publication Number Publication Date
HRP20160676T1 true HRP20160676T1 (hr) 2016-07-15

Family

ID=47357416

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20160676TT HRP20160676T1 (hr) 2011-06-17 2012-06-07 Derivati biciklo[3.1.0]heksan-2,6-dikarboksilne kiseline kao agonisti receptora mglu2

Country Status (20)

Country Link
US (1) US9296710B2 (enExample)
EP (1) EP2721012B1 (enExample)
JP (1) JP5945592B2 (enExample)
KR (1) KR101598679B1 (enExample)
CN (1) CN103596933B (enExample)
AU (1) AU2012271024B2 (enExample)
BR (1) BR112013031928B1 (enExample)
CA (1) CA2836485C (enExample)
CY (1) CY1117682T1 (enExample)
DK (1) DK2721012T3 (enExample)
EA (1) EA023553B1 (enExample)
ES (1) ES2587204T3 (enExample)
HR (1) HRP20160676T1 (enExample)
HU (1) HUE030171T2 (enExample)
MX (1) MX2013014802A (enExample)
PL (1) PL2721012T3 (enExample)
PT (1) PT2721012T (enExample)
RS (1) RS54888B1 (enExample)
SI (1) SI2721012T1 (enExample)
WO (1) WO2012173850A1 (enExample)

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006127A1 (en) 1991-09-17 1993-04-01 Warner-Lambert Company Novel amino acid prodrug renin inhibitors
US5576323A (en) 1993-12-03 1996-11-19 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5849525A (en) 1994-03-09 1998-12-15 Brigham And Women's Hospital, Inc. Compositions corresponding to a proton-coupled peptide transporter and methods of making and using same
IL124487A (en) 1995-11-16 2001-01-11 Lilly Co Eli Excitatory amino acid derivatives, their preparation and pharmaceutical compositions containing them
US5688826A (en) 1995-11-16 1997-11-18 Eli Lilly And Company Excitatory amino acid derivatives
GB9605429D0 (en) * 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
US5952294A (en) 1996-07-31 1999-09-14 University Of Pittsburgh Of The Commonwealth System Of Higher Education Peptidyl prodrugs and methods of making and using the same
ZA983930B (en) 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
DE69906492T2 (de) 1998-01-28 2003-12-18 Taisho Pharmaceutical Co., Ltd. Fluorhaltige aminosäurederivate
KR100469182B1 (ko) 1998-08-31 2005-02-02 다이쇼 세이야꾸 가부시끼가이샤 6-플루오로비시클로[3.1.0]헥산 유도체
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6770676B2 (en) 2000-06-28 2004-08-03 Taisho Pharmaceutical Co., Ltd. Dicarboxylic acid derivatives
US7038077B2 (en) 2001-01-11 2006-05-02 Eli Lilly And Company Prodrugs of excitatory amino acids
HUP0400620A3 (en) 2001-01-11 2012-09-28 Lilly Co Eli Prodrugs of excitatory amino acids and pharmaceutical compositions containing them and process for preparation the compounds
WO2002068380A1 (en) * 2001-02-22 2002-09-06 Eli Lilly And Company Synthetic excitatory amino acids
EP1395257A1 (en) 2001-06-12 2004-03-10 Elan Pharmaceuticals, Inc. Macrocycles useful in the treatment of alzheimer's disease
KR20090031962A (ko) 2001-12-27 2009-03-30 다이쇼 세이야꾸 가부시끼가이샤 6-플루오로비시클로[3.1.0]헥산 유도체
US20050192273A1 (en) 2002-04-03 2005-09-01 Johnson Bryan G. Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
AU2003218063A1 (en) 2002-04-03 2003-10-20 Eli Lilly And Company Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
KR20080058509A (ko) * 2002-06-11 2008-06-25 일라이 릴리 앤드 캄파니 흥분성 아미노산의 전구약물
CN101362793A (zh) * 2002-06-11 2009-02-11 伊莱利利公司 兴奋性氨基酸前药
ES2355144T3 (es) * 2003-06-26 2011-03-23 Taisho Pharmaceutical Co., Ltd. Derivado de éster 2-aminobiciclo 3.1.0 hexano-2,6-dicarboxílico.
US7381746B2 (en) * 2003-06-26 2008-06-03 Taisho Pharmaceutical Co., Ltd. 2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative
PT2513085T (pt) * 2009-11-18 2016-11-14 Suven Life Sciences Ltd Compostos bicíclicos como ligantes do recetor da acetilcolina nicotínico alfa4beta2
AR079343A1 (es) * 2009-12-21 2012-01-18 Lilly Co Eli Compuesto de acido 2-amino-4-(4h-1,2,4-triazol-3-ilsulfanil)biciclo[3.1.0]hexano-2,6-dicarboxilico, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar un trastorno psiquiatrico

Also Published As

Publication number Publication date
BR112013031928A2 (pt) 2016-12-13
PT2721012T (pt) 2016-07-27
EP2721012B1 (en) 2016-05-25
CN103596933A (zh) 2014-02-19
CY1117682T1 (el) 2017-05-17
HUE030171T2 (en) 2017-05-29
KR101598679B1 (ko) 2016-02-29
CN103596933B (zh) 2016-03-23
AU2012271024B2 (en) 2015-07-09
US9296710B2 (en) 2016-03-29
CA2836485C (en) 2016-12-13
SI2721012T1 (sl) 2016-08-31
EA023553B1 (ru) 2016-06-30
BR112013031928B1 (pt) 2022-05-24
MX2013014802A (es) 2014-01-24
US20140113944A1 (en) 2014-04-24
DK2721012T3 (en) 2016-08-15
PL2721012T3 (pl) 2017-05-31
KR20140009568A (ko) 2014-01-22
AU2012271024A1 (en) 2013-11-21
CA2836485A1 (en) 2012-12-20
ES2587204T3 (es) 2016-10-21
EA201391700A1 (ru) 2014-04-30
JP2014517035A (ja) 2014-07-17
JP5945592B2 (ja) 2016-07-05
RS54888B1 (sr) 2016-10-31
EP2721012A1 (en) 2014-04-23
WO2012173850A1 (en) 2012-12-20

Similar Documents

Publication Publication Date Title
EP2762476A4 (en) 1,2,4-triazine-6-carboxamide derivative
HUS1700040I1 (hu) Antivirális 1-fenil-2,5-dibenzimidazol-5-il-pirrolidin-származék
CL2014000731A1 (es) Metodo para producir derivados de 4,4-difluoro-3,4-dihidroisoquinolina
EP2792923A4 (en) PIPE CONNECTION TERMINAL
EP2774926A4 (en) morphinan
EP2673183A1 (en) Bicycle saddle
EP2825443A4 (en) ADJUSTABLE KAYAK SEAT
ME03448B (me) Farmaceutski preparat којi obuhvata antivirusno efikasan derivat dihidrohinazolina
BR112013023056A2 (pt) derivados de oxaespiro [2,5] octano e análogos
IL232463A0 (en) Antibiotic history of 2-oxo-oxazolidine-3,5-diyl
ZA201404074B (en) 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
ZA201306229B (en) Substituted 4-aryl-n-phenyl-1,3,5-triazin-2- amines
CO6870039A2 (es) 3-(bifenil-3-il)-4-hidroxi-8-metoxi-1-azaespiro[4.5]dec-3-en-2-onas sustituidas
MY165626A (en) 1,2,4,-triazolone derivative
BRDI7101139S (pt) Configuração aplicada em carenagem traseira para motocicleta.
CL2013000688A1 (es) Procedimiento para obtener una composicion de igg a partir de una composicion de igg parcialmente purificada.
DE112012002590A5 (de) Sitzversteller mit Schwinge
IT1404811B1 (it) Sella per bicicletta.
IL236473B (en) 1, 5-dihydro-2-pyrrole-one derivatives as cholecystokinin receptor ligands
BR112013011418A8 (pt) derivado de pirazino [2,3-d] isoxadol
HRP20160676T1 (hr) Derivati biciklo[3.1.0]heksan-2,6-dikarboksilne kiseline kao agonisti receptora mglu2
LU91828B1 (de) Verlängerbare Tretkurbel am Fahrrad
Schmidt et al. Splintered by stress
DK2559653T3 (da) Justerbart beslag til ridning
Velasquez Soto Divergencia latitudinal en la comunicación acústica de Pleurodema Thaul